Skip to main content
Calvin Yeang, MD, Cardiology, San Diego, CA

CalvinYeangMD

Cardiology San Diego, CA

Non-Invasive Cardiology, Preventive Cardiology

Physician

Dr. Yeang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Yeang's full profile

Already have an account?

  • Office

    UCSD Rancho Bernado
    16950 Via Tazon
    San Diego, CA 92127
    Phone+1 800-926-8273

Clinical Expertise

  • Atherosclerosis, Preventive cardiology, Lipid metabolism disorders, Lipoprotein disorders, Lipoprotein(a)

Education & Training

  • University of California (San Diego) Medical Center
    University of California (San Diego) Medical CenterFellowship, Cardiovascular Disease, 2014 - 2019
  • UC San Diego Medical Center - Hillcrest
    UC San Diego Medical Center - HillcrestPost-Doctoral Fellowship, 2014 - 2019
  • University of California (San Diego) Medical Center
    University of California (San Diego) Medical CenterResidency, Internal Medicine, 2012 - 2014
  • State University of New York Downstate Medical Center College of Medicine
    State University of New York Downstate Medical Center College of MedicineClass of 2012

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2013 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease

Publications & Presentations

PubMed

Lectures

  • Lp(a)-Cholesterol and True LDL-Cholesterol: Implications for Refining CVD Risk Attributed to LDL and Lp(a) 
    Lipoprotein(a) Symposium, EAS endorsed satellite meeting - 5/24/2019
  • The Role of Lp(a) in Calcific Aortic Valve Disease: Clinical and Basic Research Evidence 
    Heart Valve Society - 4/12/2018

Authored Content

  • The Role of Lipoprotein(A) in Calcific AV Disease and Insights into Its Medical TherapiesApril 2020
  • The Role of Lipoprotein(A) in Calcific AV Disease and Insights into Its Medical TherapiesApril 2020
  • PET/MR Imaging of Malondialdehyde-Acetaldehyde Epitopes with a Human Antibody Detects Clinically Relevant AtherothrombosisJanuary 2018
  • PET/MR Imaging of Malondialdehyde-Acetaldehyde Epitopes with a Human Antibody Detects Clinically Relevant AtherothrombosisJanuary 2018
  • Join now to see all

Grant Support

  • Defining the Role of Lipoprotein(a) and its Oxidized Phospholipids in the Development and Progression of Calcific Aortic Valve Disease Using Unique Transgenic Mouse ModelsNIH/NHLBI2020–2025

Professional Memberships

Other Languages

  • Chinese (Mandarin)